Laura C. Pinheiro

Laura C. Pinheiro

Auto-generated profile, based on publicly available information

Laura C. Pinheiro

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cancer Cell
Verified
Journal Article
Closed access
LWLars F. Westblade
Lars F. Westblade
GBGagandeep Brar
Gagandeep Brar
LPLaura C. Pinheiro
Laura C. Pinheiro
DPDemetrios Paidoussis
Demetrios Paidoussis
MRMangala Rajan
Mangala Rajan
MSMichael J. Satlin
Michael J. Satlin

3 September 2021 in Cancer
Verified
Journal Article
Closed access
PDF file
LPLaura C. Pinheiro
Laura C. Pinheiro
EREvgeniya Reshetnyak
Evgeniya Reshetnyak
TATomi Akinyemiju
Tomi Akinyemiju
EPErica Phillips
Erica Phillips
MSMonika M. Safford
Monika M. Safford

28 September 2020 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
GBGagandeep Brar
Gagandeep Brar
LPLaura C. Pinheiro
Laura C. Pinheiro
MSMichael Shusterman
Michael Shusterman
BSBrandon Swed
Brandon Swed
EREvgeniya Reshetnyak
Evgeniya Reshetnyak
MSManish A Shah
Manish A Shah
PURPOSE: SARS-CoV-2 (COVID-19) is a systemic infection. Patients with cancer are immunocompromised and may be vulnerable to COVID-related morbidity and mortality. The objectives of this study were to determine if patients with cancer have worse outcomes compared with patients without cancer and to identify demographic and clinical predictors of morbidity and mortality among patients with cancer.METHODS: We used data from adult patients who tested positive for COVID-19 and were admitted to two New York–Presbyterian hospitals between March 3 and May 15, 2020. Patients with cancer were matched 1:4 to controls without cancer in terms of age, sex, and number of comorbidities. Using Kaplan-Meier curves and the log-rank test, we compared morbidity (intensive care unit admission and intubation) and mortality outcomes between patients with cancer and controls. Among those with cancer, we identified demographic and clinical predictors of worse outcomes using Cox proportional hazard models.RESULTS: We included 585 patients who were COVID-19 positive, of whom 117 had active malignancy, defined as those receiving cancer-directed therapy or under active surveillance within 6 months of admission. Presenting symptoms and in-hospital complications were similar between the cancer and noncancer groups. Nearly one half of patients with cancer were receiving therapy, and 45% of patients received cytotoxic or immunosuppressive treatment within 90 days of admission. There were no statistically significant differences in morbidity or mortality ( P = .894) between patients with and without cancer.CONCLUSION: We observed that patients with COVID-19 and cancer had similar outcomes compared with matched patients without cancer. This finding suggests that a diagnosis of active cancer alone and recent anticancer therapy do not predict worse COVID-19 outcomes and therefore, recommendations to limit cancer-directed therapy must be considered carefully in relation to cancer-specific outcomes and death.

3 December 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
MSMonika M. Safford
Monika M. Safford
EREvgeniya Reshetnyak
Evgeniya Reshetnyak
MSMadeline R. Sterling
Madeline R. Sterling
JRJoshua S. Richman
Joshua S. Richman
PMPaul M. Muntner
Paul M. Muntner
LPLaura C. Pinheiro
Laura C. Pinheiro
Background: Social determinants of health (SDH) are individually associated with incident coronary heart disease (CHD) events. Indices reflecting social deprivation have been developed for population management, but are difficult to operationalize during clinical care. We examined whether a simple count of SDH is associated with fatal incident CHD and nonfatal myocardial infarction (MI). Methods: We used data from the prospective longitudinal REasons for Geographic And Racial Differences in Stroke cohort study, a national population-based sample of community-dwelling Black and white adults age ≥45 years recruited from 2003-7. Seven SDH from the five Healthy People 2020 domains included social context (Black race, social isolation); education (educational attainment); economic stability (annual household income); neighborhood (living in a zip code with high poverty); and healthcare (lacking health insurance, living in one of the 9 US states with the least public health infrastructure). Outcomes were expert adjudicated fatal incident CHD and nonfatal MI. Results: Of 22,152 participants free of CHD at baseline, 58.8% were women, 42.0% were Blacks, 20.6% had no SDH, 30.6% had 1, 23.0% had 2, and 25.8% had ≥3. There were 463 fatal incident CHD events and 932 nonfatal MIs over median 10.7 years [IQR 6.6-12.7]. Fewer SDH were associated with nonfatal MI than with fatal incident CHD. The age-adjusted incidence per 1000 person-years increased with the number of SDH for both fatal incident CHD (0 SDH 1.30, 1 SDH 1.44, 2 SDH 2.05, ≥3 SDH 2.86) and nonfatal MI (0 SDH 3.91, 1 SDH 4.33, ≥2 SDH 5.44). Compared to those without SDH, crude and fully adjusted hazard ratios (HR) for fatal incident CHD among those with ≥3 SDH were 3.00 (95% CI 2.17, 4.15) and 1.67 (95% CI 1.18, 2.37), respectively; and that for nonfatal MI among those with ≥2 SDH were 1.57 (95% CI 1.30, 1.90) and 1.14 (0.93, 1.41), respectively. Conclusions: A greater burden of SDH was associated with a graded increase in risk of incident CHD, with greater magnitude and independent associations for fatal incident CHD. Counting the number of SDH may be a promising approach that could be incorporated into clinical care to identify individuals at high risk of CHD.

6 September 2017 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
LPLaura C. Pinheiro
Laura C. Pinheiro
MMMolly McFatrich
Molly McFatrich
NLNicole Lucas
Nicole Lucas
JWJennifer S. Walker
Jennifer S. Walker
JWJanice S. Withycombe
Janice S. Withycombe
BRBryce B. Reeve
Bryce B. Reeve

17 November 2020 in Annals of Internal Medicine
Verified
Journal Article
Open access
PGParag Goyal
Parag Goyal
JRJoanna Bryan Ringel
Joanna Bryan Ringel
MRMangala Rajan
Mangala Rajan
JCJustin J. Choi
Justin J. Choi
LPLaura C. Pinheiro
Laura C. Pinheiro
MSMonika M. Safford
Monika M. Safford